Need Help? Call 1­-866-­796-­7386
« back to stock screener

  PRPH stock: ProPhase Labs Inc

Current Rating
Strong Buy

Previous Rating:

Strong Buy
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$2.04
Market Cap
33.6M
Sector
Health Care
Div. Growth
-
P/E
2.4
P/B
0.7
P/S
2.17
Dividend %
-
P/CF
0.9
P/FCF
37.3
Op. Cash Flow
1.5K
FCF
0.0
Op. Margin
-15.40%
Net Margin
262.60%
ROE
248.00%
ROI
-35.40%
ROA
182.10%
EPS Growth
-
Current Ratio
1.4
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Aralez Pharmaceuticals Inc (ARLZ) $1.27 - - 91.5M Strong Buy
Biostar Pharmaceuticals Inc (BSPM) $1.45 - - 4M Strong Buy
Birner Dental Mgmt Services In (BDMS) $12.25 - 6.50% 25.1M Strong Buy
Palatin Technologies, Inc. (PTN) $0.44 - - 62.6M Strong Buy
Navidea Biopharmaceuticals Inc (NAVB) $0.46 - - 83.4M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More